van Dijk, Floor;
de Wit, Iris;
Blankers, Matthijs;
Sommer, Iris;
de Haan, Lieuwe
The Personal Antipsychotic Choice Index : Introducing a Tool for Shared Decision-Making in Selecting Antipsychotic Medication
: Introducing a Tool for Shared Decision-Making in Selecting Antipsychotic Medication
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
The Personal Antipsychotic Choice Index : Introducing a Tool for Shared Decision-Making in Selecting Antipsychotic Medication
:
Introducing a Tool for Shared Decision-Making in Selecting Antipsychotic Medication
Beteiligte:
van Dijk, Floor;
de Wit, Iris;
Blankers, Matthijs;
Sommer, Iris;
de Haan, Lieuwe
Beschreibung:
<jats:title>Abstract</jats:title><jats:p>
Introduction We present an online decision aid to involve patients with a psychotic disorder in shared decision-making concerning the selection of antipsychotic medication.</jats:p><jats:p>
Method Patients selected effectiveness and adverse effects criteria from the Subject’s Response to Antipsychotics-34 questionnaire. Numerical data from meta-analyses, clinical trial data, receptor affinities and expert opinions were used to rank antipsychotics on each criterion. When using the the tool, patients indicate on a 5-point Likert scale how they value each (adverse) effect. The Likert scale values are combined in an algorithm with the rank orders of antipsychotics to create a personalized ranking.</jats:p><jats:p>
Results Criteria used were: effectiveness concerning psychotic, depressive and cognitive symptoms, weight gain, sexual dysfunction, drowsiness, hypersomnia, extrapyramidal symptoms, anticholinergic adverse effects, hypersalivation, nausea, dizziness, energy loss, blunted affect/less need for companionship. High-level evidence was available for ranking weight gain, sexual dysfunction, menstrual disorders, extrapyramidal symptoms and effectiveness on psychotic symptoms. We used lower level evidence ranking the remaining criteria.</jats:p><jats:p>
Discussion A transparent procedure has resulted in an updateable tool to produce individual ranking of antipsychotics based on the patients’ input.</jats:p>